We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





GNA Biosolutions Reveals New Ultrafast PCR Platform at Medical Trade Show

By HospiMedica International staff writers
Posted on 13 Nov 2022
Print article
Image: The Pharos V8 laser PCR platform (Photo courtesy of GNA Biosolutions).
Image: The Pharos V8 laser PCR platform (Photo courtesy of GNA Biosolutions).
GNA Biosolutions GmbH (Martinsried, Germany), a molecular technology company, will showcase its new Pharos V8, the world's first laser PCR platform, at MEDICA 2017.

GNA Biosolutions specializes in sample-to-result applications across medical diagnostics, biosecurity, food safety, and life sciences. The company develops instruments, OEM modules and applications for ultrafast molecular assays based on proprietary technology protected by a comprehensive patent portfolio.

The Pharos V8, an ultrafast PCR instrument for in vitro research use, uses the patented Laser PCR technology, which operates on the same principles as conventional nucleic acid amplification with PCR (Polymerase Chain Reaction). However, Laser PCR uses nanomaterials to control temperature cycles at the nano scale, accelerating PCR reaction times by a factor of ten and opening the door for applications in multiple time-sensitive settings.

Some of the key features of the Pharos V8 include an open platform for universal PCR assay development, ultrafast real-time nucleic acid detection in 10 minutes or less, and intuitive interface with easy-to-use software that can be accessed remotely.

“We are excited to present our first Laser PCR platform, the Pharos V8, at this year's Medica,” said Frank Krieg-Schneider, CEO of GNA Biosolutions. “We believe the Pharos V8 will demonstrate the power of our patented technology to deliver ultrafast molecular results, and pave the way for additional platforms in development for diagnostic testing and point of care.”

Related Links:
GNA Biosolutions
Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Mobile Power Procedure Chair
LeMans P360
New
Mattress Replacement System
Carilex DualPlus

Print article

Channels

Surgical Techniques

view channel
Image: The surgical team and the Edge Multi-Port Endoscopic Surgical Robot MP1000 surgical system (Photo courtesy of Wei Zhang)

Endoscopic Surgical System Enables Remote Robot-Assisted Laparoscopic Hysterectomy

Telemedicine enables patients in remote areas to access consultations and treatments, overcoming challenges related to the uneven distribution and availability of medical resources. However, the execution... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.